Members of the national Covid-19 working group clarified that Covaxin, the vaccine being developed by Bharat Biotech, would be used in a “clinical trial” mode and Union Health Minister Harsh Vardhan said his approval of use emergency was “a strategic decision for our vaccine.” security.” But some independent scientists said …
Read More »
The company has already stockpiled about 50 million doses of the vaccine. The Serum Institute of India (SII) said on Sunday that it is ready to launch the Covishield vaccine in the country in the coming weeks after receiving approval from India’s drug regulator. The Pune-based vaccine specialist has started …
Read More »
One day after Samajwadi Party chief Akhilesh Yadav questioned India’s Covid-19 vaccines and said he would not take “the BJP vaccine,” Congressional leaders Jairam Ramesh, Shashi Tharoor also doubted approval. awarded to the Bharat Biotech vaccine while in its third phase of testing. . Criticizing their doubts, Union Minister Hardeep …
Read More »
After the Controller General of Drugs of India (DCGI) gave the green signal on Sunday to two candidate vaccines for restricted and emergency use, Union Minister Rajnath Singh praised Prime Minister Narendra Modi’s vision for Aatmanirbhar Bharat, who said that he has greatly helped India to come. with indigenous solutions …
Read More »
NEW DELHI: As India prepares for the world’s largest vaccination program, India’s Controller General of Drugs (DCGI) on Sunday quelled rumors surrounding Covid-19 vaccines regarding impotence, dismissing those speculations as “complete nonsense”. “We will never approve anything if there is the slightest concern for safety. Vaccines are 110% safe. Some …
Read More »
For the executive director of the Serum Institute of India, Adar Poonawalla, the moment of happy new year came on January 3 after the General Controller of Drugs of India on Sunday gave the final go-ahead to Covishield, the vaccine developed by the Oxford University and leading pharmaceutical Astrazeneca and …
Read More »
The head of India’s drug regulator will deliver a press conference on Sunday, a day after his experts recommended allowing the emergency use in the country of the Oxford-AstraZeneca and Bharat Biotech vaccines against the coronavirus disease ( Covid-19), according to reports. . The Comptroller General of Drugs of India …
Read More »
Bharat Biotech vaccine candidate approved for use in clinical trial mode. The first COVID-19 vaccine developed in India, Covaxin, has been recommended for “restricted use in emergency situations, subject to multiple regulatory conditions” by the Subject Matter Expert Committee (SEC) of the Central Medicines Control Organization ( CDSCO), here on …
Read More »
Covaxin has been indigenously developed in collaboration with ICMR. An expert panel from India’s central drug authority recommended on January 2 to grant permission for the emergency restricted use of the locally developed COVID-19 vaccine Covaxin with certain conditions, a day after giving similar instructions for the COVID vaccine. -19 …
Read More »
New Delhi: India is likely to have a Covid-19 vaccine in the New Year, India’s general drug controller VG Somani hinted on Thursday. Speaking at a webinar, Somani said most importantly, industry and research organizations have stood the test of time. He said that the vaccine candidates got the funding …
Read More »